Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K140382
    Date Cleared
    2014-11-25

    (284 days)

    Product Code
    Regulation Number
    878.3720
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    AEROMINI TRACHEOBRONCHIAL STENT TECHNOLOGY

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The MERIT ENDOTEK AEROmini Tracheobronchial Stent System is indicated for use in the treatment of tracheobronchial strictures produced by malignant neoplasms.

    Device Description

    The MERIT ENDOTEK AEROmini Tracheobronchial Stent System is comprised of two components: the radiopaque self-expanding nitinol stent and the delivery system. The stent is completely covered with a biocompatible polyurethane membrane. The stent expansion results from the physical properties of the metal and the proprietary geometry. The overall stent geometry is designed to maintain a constant length over the entire range of possible diameters. As a result of this unique design the stent has virtually no foreshortening, thus facilitating the selection of the appropriate stent length. The stent is deployed endoscopically with a dedicated delivery system with or without the aid of fluoroscopic imaging. The delivery system consists of two coaxial sheaths. The exterior sheath serves to constrain the stent until the sheath is retracted during deployment. The stent remains constrained by the delivery system until the trigger is pulled beyond the white deployment threshold mark located between the trigger and hand grip. This feature allows for repositioning of the stent proximally. In addition, the procedure can be aborted and the entire system can be withdrawn en bloc at any time before the trigger is pulled beyond the white deployment threshold mark located between the trigger and hand grip. A radiopaque tip and marker on the inner shaft aid the operator in determining stent position in relation to the deployment threshold mark, where repositioning or en bloc withdrawal is no longer possible. The inner sheath of the delivery system contains a central lumen that will accommodate a 0.035" guide wire. This feature is designed to allow guidance of the delivery system to the intended implant site while minimizing the risk of airway injury from the delivery system tip.

    AI/ML Overview

    The provided text describes the regulatory clearance of the AEROmini™ Tracheobronchial Stent System, focusing on its substantial equivalence to a predicate device rather than a study proving the device meets predefined acceptance criteria for AI/algorithm performance. Therefore, most of the requested information regarding AI/algorithm performance, such as sample sizes for test/training sets, expert ground truth, adjudication methods, MRMC studies, or standalone performance, is not available in the given document.

    However, the document does list the acceptance criteria in general terms, and states that studies were conducted to meet these criteria, thereby demonstrating substantial equivalence.

    Here's the information that can be extracted:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria Category (as per FDA Guidance and Recognized Standards)Reported Device Performance
    Mechanical Performance (based on FDA Guidance for Esophageal and Tracheal Prosthesis)All tests successfully conducted, demonstrating adherence to established criteria and substantial equivalence. Specific tests include:
    Deployment TestingSuccessfully conducted
    Expansion Force TestingSuccessfully conducted
    Compression Force TestingSuccessfully conducted
    Dimensional TestingSuccessfully conducted
    Tensile Strength TestsSuccessfully conducted
    Guide Wire CompatibilitySuccessfully completed
    Delivery Device Working LengthSuccessfully completed
    Delivery Device Stent Pod ODSuccessfully completed
    Delivery Device Shaft ODSuccessfully completed
    Trigger StrokeSuccessfully completed
    Insertion ForceSuccessfully completed
    Distal Tip Insertion & Flexibility/Kink Resistance PerformanceSuccessfully completed
    Repositioning TestsSuccessfully completed
    Delivery System Deployment AccuracySuccessfully completed
    Stent Expansion & Condition After DeploymentSuccessfully completed
    System IntegritySuccessfully completed
    Stent ForeshorteningSuccessfully completed
    Removal Migration & Removal ForceSuccessfully completed
    AM-Strut HeightSuccessfully completed
    Suture Purse String Suture TensileSuccessfully completed
    Stent TensileSuccessfully completed
    Stent FatigueSuccessfully completed
    Cover Integrity After FatigueSuccessfully completed
    Coating Integrity After FatigueSuccessfully completed
    Stent Spring Back After FatigueSuccessfully completed
    Compression Force After FatigueSuccessfully completed
    Expansion Force After FatigueSuccessfully completed
    Trigger SafetySuccessfully completed
    Delivery System Tensile Strength TestsSuccessfully completed
    Imaging CompatibilityAll tests successfully conducted, demonstrating adherence to established criteria and substantial equivalence. Specific tests include:
    Fluoroscopic Visibility of Deployment CatheterSuccessfully completed
    Endoscopic Visibility of Deployment CatheterSuccessfully completed
    MR Compatibility (ASTM F2052, F2119, F2182, F2213, F2503)Successfully completed
    Biocompatibility (ISO 10993 series)All tests successfully conducted, demonstrating adherence to established criteria and substantial equivalence. Specific tests include:
    Cytotoxicity (ISO 10993-5)Successfully completed
    Sensitization (ISO 10993-10)Successfully completed
    Implantation (ISO 10993-6)Successfully completed
    Irritation (ISO 10993-10)Successfully completed
    Material Mediated Pyrogenicity (USP 36)Successfully completed
    Chemical Characterization (ISO 10993-17, 10993-18)Successfully completed
    Sterilization (ISO 11135-1, ISO 10993-7)All tests successfully conducted, demonstrating adherence to established criteria and substantial equivalence. Specific tests include:
    Ethylene Oxide Sterilization ResidualsSuccessfully completed
    Packaging Performance (ISO11607-1, ASTM D4169, ISO 2233)All tests successfully conducted, demonstrating adherence to established criteria and substantial equivalence. Specific tests include:
    Seal Peel StrengthSuccessfully completed
    Visual InspectionSuccessfully completed
    Bubble EmissionSuccessfully completed
    Atraumatic TipSuccessfully completed

    2. Sample size used for the test set and the data provenance:

    • Not applicable as this document does not describe an AI/algorithm-based study. The performance testing refers to physical and material properties of the medical device itself. No specific sample sizes for these tests are provided in the summarized information beyond noting that "a battery of tests was performed."
    • Data provenance: Not specified. This typically refers to laboratory testing of the physical device components and system.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not applicable. Ground truth in the context of AI/algorithm performance is not relevant here. The "ground truth" for the device's performance is established by recognized performance standards and guidance documents (e.g., ISO, ASTM, FDA guidance), against which the device's physical and biological properties are measured.

    4. Adjudication method for the test set:

    • Not applicable. Adjudication methods are typically used in clinical studies or expert review processes for AI algorithms. Here, device performance is measured against objective technical standards.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • No. This document describes a traditional medical device (stent) and its physical, mechanical, and biological performance characteristics, not an AI or imaging diagnostic device that would involve human readers.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    • No. Not an AI/algorithm.

    7. The type of ground truth used:

    • The "ground truth" for this device's performance is based on recognized performance standards and guidance documents (e.g., FDA Guidance for the Content of Premarket Notifications for Esophageal and Tracheal Prosthesis, ISO, and ASTM standards) which define the expected physical, mechanical, and biological properties for tracheal prostheses.

    8. The sample size for the training set:

    • Not applicable. No AI/algorithm training set.

    9. How the ground truth for the training set was established:

    • Not applicable. No AI/algorithm training set.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1